- 著者
-
Cabral Horacio
垣見 和宏
内田 智士
- 出版者
- 東京大学
- 雑誌
- 基盤研究(B)
- 巻号頁・発行日
- 2020-04-01
We will first develop a series of T-cell targeted mRNA-loaded nanocarriers. These nanocarriers will be optimized for stability, targeting and protein production in vitro.Promising formulations will then be tested in vivo. to determine the targeting efficacy to the CD8 T cells, the production of CAR T cell in situ and the antitumor activity against models of leukemia and solid tumors. Finally, we will check the toxicity of the treatments.